Chameleon Biosciences, Inc. — Form D
Chameleon Biosciences, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-25. The offering totals $23.0M, of which $10.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-25
- Form: D
- Accession: 0001853082-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.0M
- Amount sold: $10.6M
- Remaining: $12.4M
- Investors: 23
- Date of first sale: 2021-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393537
Issuer
- Name: Chameleon Biosciences, Inc.
- CIK: 0001853082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 626 BANCROFT WAY, SUITE A, BERKELEY, CA, 94710
- Phone: 510-990-3089
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ran A Geng | Director | Berkeley, CA |
| Winnie A Wan | Director | Berkeley, CA |
| Genine A Winslow | Director | Berkeley, CA |
| Genine A Winslow | Executive Officer | Berkeley, CA |
More